Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for March 2007
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Judicial review on Alzheimer's drugs to go ahead
High Court judge agrees there are grounds to challenge NICE's decision..(more)

 US News Roundup
US product news from Datamonitor..(more)

 European News Roundup
EU product news from Datamonitor..(more)

 AstraZeneca's pipeline suffers another blow
Coronary drug AGI-1067 fails to meet its phase III endpoint..(more)

 Diabetes UK report criticises cutbacks in NHS
Charity says service reductions are putting patients at risk..(more)

 Eisai to buy biotech Morphotek
Acquisition brings biotech expertise and technology in-house..(more)

 Schering acquisition boosts Bayer's 2006 turnover figures
But success comes at cost of 6,100 lost jobs..(more)

 Abbott withdraws HIV drugs from Thailand after patent row
Angry AHF brands company "heartless"..(more)

 Schering-Plough to buy Organon for 11 billion euros
Deal gives company access to potential schizophrenia blockbuster..(more)

 Shire to raise Alzheimer's awareness
Company appoints hsd for its Reminyl campaign..(more)

 Servier "named and shamed" for sales slides
Company disciplined after training aids deemed to encourage predatory behaviour..(more)

 BMS expands Indian biotech collaboration
New Bangalore R&D centre could house more than 400 scientists..(more)

 New diabetes drug launched in UK
Byetta shows advantages over insulin in type II diabetes..(more)

 Tyverb gains first approval in US
Potential Herceptin rival could have peak sales in excess of $3bn..(more)

 Shire dispels doubts about New River acquisition
Reports of a rival bidder in the $2.6bn deal are discounted..(more)

 PM hints pharma could avoid 'value-based' pricing
ABPI welcomes government caution on adoption of OFT's recommendations..(more)

 NICE judges Tarceva too expensive for NHS
But further research recommended for specific patient subgroups..(more)

 Huntsworth makes US acquisition
Purchase of Dorland extends agency's presence in US pharma..(more)

 Doctors reassured by hospital reconfiguration report
Sir Ian Carruthers says patients' clinical needs must be priority..(more)

 Merck lung cancer vaccine enters phase III trials
Novel therapy Stimuvax already showing promising results ..(more)

 Work begins on Eisai's Knowledge Centre
New £100m Hatfield base will create more than 500 jobs..(more)

 Academy launched to fill NHS training need
Survey shows doctors would welcome pharma-sponsored courses..(more)

 GSK to test Tycerb for head and neck cancer
New indication could give further boost to potential blockbuster breast cancer drug..(more)

 Eisai prepares for Inovelon UK launch
Orphan epiliepsy drug should be on market by June..(more)

 Pfizer's controversial new UK supply chain goes live
UniChem becomes Pfizer's sole wholesale supplier in UK..(more)

 Two products fuelling Actelion's growth spurt
Policy of focusing on high unmet medical need pays off..(more)

 New clinical trials network to boost patient recruitment in UK
Government gives £2m annual funding for Primary Care Research Network ..(more)

 Court orders withdrawal of generic Lipitor in Denmark
Ranbaxy's atorvastatin blocked after just 11 days on sale..(more)

 Novartis' 2-in-1 blood pressure drug Exforge launched in the UK
And company has high hopes for its unlaunched BP drug, Tekturna..(more)

 Sales data specialists Cegedim to buy rivals Dendrite
The combined company will have greater global reach..(more)

 Prime Minister opens Amgen European R&D centre
New centre employs 300 to work on company's expanding pipeline..(more)

 Sanofi-Aventis growth stifled by Plavix and price cuts
But company remains optimistic despite difficult times ahead..(more)

 Doctors attack 'nonsensical' NHS cost-cutting
Operations delayed in bid to balance the books..(more)

 US approval for Shire's Vyvanse
But unlikley that drug will be filed in Europe before 2009..(more)

 Radical overhaul of NHS prescription drug prices recommended
Office of Fair Trading supports system based on patient benefit proposed..(more)

 Pfizer to submit evidence to NICE inquiry
Select committee invites stakeholders to make written submissions..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.